Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
November 19, 2024
Tickers
REGN
Tags
Options
Benzinga
REGN
From
Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
November 18, 2024
Tickers
REGN
Tags
Market News
BZI/SHORTHIST
Short Ideas
From
Benzinga
Check Out What Whales Are Doing With REGN
November 15, 2024
Tickers
REGN
Tags
REGN
Benzinga
Options
From
Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
Tickers
NEWS
REGN
SNY
Tags
Market News
FDA
Benzinga
From
Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
November 14, 2024
Tickers
REGN
Tags
Benzinga
REGN
BZI/AAR
From
Benzinga
2 Top Growth Stocks to Buy on the Dip
November 14, 2024
Tickers
LLY
REGN
Tags
Recent Press Releases
REGN
LLY
From
Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
Tickers
AZN
GSK
NEWS
REGN
Tags
General
Briefs
SNY
From
Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
November 06, 2024
Tickers
NEWS
REGN
Tags
REGN
News
Benzinga
From
Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
November 06, 2024
Tickers
ASML
DELL
IDXX
MRNA
Tags
DELL
MRNA
IDXX
From
Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
Tickers
AMGN
AZN
NEWS
REGN
Tags
SNY
why it's moving
Briefs
From
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
November 04, 2024
Tickers
REGN
Tags
REGN
Benzinga
Options
From
Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
Tickers
NEWS
NVO
REGN
SNY
Tags
Health Care
REGN
Biotech
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
Macro Economic Events
AAPL
Benzinga
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
CATX
Equities
Large Cap
From
Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
October 28, 2024
Tickers
EYPT
NEWS
REGN
Tags
Movers
News
Briefs
From
Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
October 28, 2024
Tickers
AMGN
CMG
GS
LLY
Tags
AMGN
NVDA
CMG
From
Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
October 25, 2024
Tickers
LLY
NEWS
REGN
SNY
Tags
Stories That Matter
SNY
Briefs
From
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $5,800 Today
October 24, 2024
Tickers
NEWS
REGN
Tags
Market News
Trading Ideas
Benzinga
From
Benzinga
A Closer Look at 23 Analyst Recommendations For Regeneron Pharmaceuticals
October 23, 2024
Tickers
REGN
Tags
Benzinga
BZI/AAR
REGN
From
Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
October 23, 2024
Tickers
NEWS
REGN
Tags
Trading Ideas
Benzinga
BZI/IA
From
Benzinga
Seagate To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Wednesday
October 23, 2024
Tickers
MCD
MCO
NEWS
NSC
Tags
MCO
Benzinga
Trading Ideas
From
Benzinga
Market Whales and Their Recent Bets on REGN Options
October 23, 2024
Tickers
REGN
Tags
BZI/UOA
Markets
Market News
From
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
October 10, 2024
Tickers
NEWS
REGN
Tags
REGN
BZI/POD
News
From
Benzinga
What the Options Market Tells Us About Regeneron Pharmaceuticals
October 10, 2024
Tickers
REGN
Tags
Markets
BZI/UOA
Market News
From
Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
October 09, 2024
Tickers
AMGN
AZN
BMRN
GILD
Tags
Top Stories
Stories That Matter
AMGN
From
Benzinga
Inquiry Into Regeneron Pharmaceuticals's Competitor Dynamics In Biotechnology Industry
October 09, 2024
Tickers
NEWS
REGN
Tags
News
REGN
Markets
From
Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
October 07, 2024
Tickers
LLY
NEWS
NVO
REGN
Tags
News
Briefs
General
From
Benzinga
Should You Buy the Dip on This Top Growth Stock?
October 05, 2024
Tickers
AMGN
REGN
Tags
Market News
REGN
AMGN
From
Motley Fool
A Closer Look at 24 Analyst Recommendations For Regeneron Pharmaceuticals
October 04, 2024
Tickers
REGN
Tags
Benzinga
REGN
BZI/AAR
From
Benzinga
Market Whales and Their Recent Bets on REGN Options
October 03, 2024
Tickers
REGN
Tags
Options
Benzinga
REGN
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.